NCT04971226 2026-03-10A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CPNovartisPhase 3 Active not recruiting406 enrolled 18 charts 1 FDA
NCT04258943 2025-09-18Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid LeukemiaChildren's Oncology GroupPhase 1/2 Active not recruiting60 enrolled 1 FDA